UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Aaron Wealth Advisors LLC

Aaron Wealth Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,468 shares of the healthcare conglomerate’s stock after buying an additional 318 shares during the period. Aaron Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $2,260,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Pacer Advisors Inc. lifted its position in UnitedHealth Group by 5.7% during the second quarter. Pacer Advisors Inc. now owns 65,860 shares of the healthcare conglomerate’s stock valued at $33,540,000 after buying an additional 3,525 shares in the last quarter. Garden State Investment Advisory Services LLC grew its position in UnitedHealth Group by 13.5% in the second quarter. Garden State Investment Advisory Services LLC now owns 1,049 shares of the healthcare conglomerate’s stock valued at $536,000 after acquiring an additional 125 shares in the last quarter. Columbus Hill Capital Management L.P. acquired a new position in UnitedHealth Group in the 2nd quarter worth $14,789,000. Summit Trail Advisors LLC increased its position in shares of UnitedHealth Group by 33.3% during the second quarter. Summit Trail Advisors LLC now owns 12,008 shares of the healthcare conglomerate’s stock worth $6,115,000 after acquiring an additional 2,999 shares during the last quarter. Finally, Transatlantique Private Wealth LLC grew its stake in UnitedHealth Group by 9.9% during the 2nd quarter. Transatlantique Private Wealth LLC now owns 2,594 shares of the healthcare conglomerate’s stock valued at $1,291,000 after purchasing an additional 234 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on UNH shares. Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Barclays reduced their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday. Morgan Stanley cut their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. TD Cowen upped their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. Finally, Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. Two analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and an average price target of $627.74.

UnitedHealth Group Stock Down 0.1 %

Shares of UNH stock opened at $510.03 on Friday. The business’s fifty day moving average is $549.37 and its 200-day moving average is $562.73. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The stock has a market cap of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter last year, the firm posted $5.83 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.